Idogen recruits a new Chief Medical Officer
Idogen AB (“Idogen”) announces that Christina Brattström has been appointed Chief Medical Officer. She has solid experience in clinical development of transplantation drugs, and over 20 years of experience in senior medical roles at international pharmaceutical companies. Christina Brattström will be part of the company’s executive management and will take up her post on 1 April 2020. Christina Brattström is a physician and completed her graduate studies at Karolinska Institutet, where she worked as Associate Professor and was responsible for clinical drug trials in transplantation